Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation

Blood

Volumn 96, Issue 12, 2000, Pages 3915-3921

  Cirinna, M ^a   Trotta, R ^a   Salomoni, P ^a   Kossev, P ^a   Wasik, M ^a   Perrotti, D ^a   Calabretta, B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAD; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034548831     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3915.h8003915_3915_3921     Document Type: Article

References (45)

1. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL)
2. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
3. Presence of the bcr/abl rearrangement in a patient with chronic neutrophilic leukaemia
4. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript
5. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210bcr/abl protein
6. Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro
7. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
8. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death
9. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis
10. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant
11. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
12. Acute leukaemia in bcr/abl transgenic mice
13. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
14. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
15. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: Implication for RAS-dependent Philadelphia chromosome positive cell growth
16. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr/Abl oncogene
17. The Bcd/Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
18. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants
19. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
20. Transformation of hematopoietic cells by BCR/ABL requires the activation of a PI-3k/Akt-dependent pathway
21. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
22. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats
23. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
24. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
25. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
26. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a RAS-dependent signaling pathway
27. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL 2
28. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: Protection is correlated with up regulation of Bcl-xL
29. Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras
30. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
31. Production of high-titer helper-free retroviruses by transient transfection
32. Cytokine-dependent granulocytic differentiation: Regulation of proliferative and differentiative responses in a murine progenitor cell line
33. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome C release during apoptosis
34. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase
35. Bcl-2 targets the protein kinase Raf-1 to mitochondria
36. BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac
37. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
38. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
39. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner
40. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers
41. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
42. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
43. Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification
44. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma